Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis

被引:54
作者
Arakawa, K [1 ]
Urata, H [1 ]
机构
[1] Fukuoka Univ, Dept Internal Med, Sch Med, Jonan Ku, Fukuoka 8140180, Japan
关键词
kallikrein; angiotensin-converting enzyme; atherosclerosis; cardiovascular diseases;
D O I
10.1161/01.HYP.36.4.638
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The renin-angiotensin system has been studied and recognized as one of the major blood pressure-regulating systems for the past century. In the last quarter century, however, many alternative pathways of angiotensin II formation have been found, and among them, chymase has been a focus of interest because of its specificity and potency in the human cardiovascular system. Chymase evidently is not involved in functional regulation of blood pressure at least in the short term. but evidence is accumulating that it may be involved in structural remodeling of the cardiovascular system. We found increased vascular chymase activity in atherosclerotic lesions of the human aorta as well as in cardiac remodeling after myocardial infarction. We found a significant positive correlation between serum total or LDL cholesterol levels and arterial chymase-dependent angiotensin II-forming activity in patients who were undergoing coronary artery bypass operation, suggesting that high serum cholesterol may trigger upregulation of vascular chymase and facilitate the development of atherosclerosis. This hypothesis was tested in Syrian hamsters fed a high cholesterol diet containing 0.5% cholesterol: A marked lipid deposition in the aortic cusp developed and the plasma cholesterol levels were positively correlated with aortic chymase activity. An orally active nonpeptide chymase inhibitor almost canceled this lipid deposition. These clinical and experimental data indicated an association between cholesterol and vascular chymase upregulation that may facilitate the development of atherosclerosis.
引用
收藏
页码:638 / 641
页数:4
相关论文
共 25 条
  • [1] Differences in tissue angiotensin II-forming pathways by species and organs in vitro
    Akasu, M
    Urata, H
    Kinoshita, A
    Sasaguri, M
    Ideishi, M
    Arakawa, K
    [J]. HYPERTENSION, 1998, 32 (03) : 514 - 520
  • [2] PRESSOR FORMATION BY TRYPSIN FROM RENIN-DENATURED HUMAN-PLASMA PROTEIN
    ARAKAWA, K
    IKEDA, M
    FUKUYAMA, J
    SAKAI, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (03) : 599 - 602
  • [3] ABILITY OF KALLIKREIN TO GENERATE ANGIOTENSIN-II-LIKE PRESSOR SUBSTANCE AND A PROPOSED KININ-TENSIN ENZYME-SYSTEM
    ARAKAWA, K
    MARUTA, H
    [J]. NATURE, 1980, 288 (5792) : 705 - 706
  • [4] Arakawa K, 1996, J HYPERTENS, V14, pS3
  • [5] GONDO M, 1989, JPN HEART J, V30, P219
  • [6] Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta
    Ihara, M
    Urata, H
    Kinoshita, A
    Suzumiya, J
    Sasaguri, M
    Kikuchi, M
    Ideishi, M
    Arakawa, K
    [J]. HYPERTENSION, 1999, 33 (06) : 1399 - 1405
  • [7] Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide
    Kofford, MW
    Schwartz, LB
    Schechter, NM
    Yager, DR
    Diegelmann, RF
    Graham, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) : 7127 - 7131
  • [8] Kokkonen JO, 1997, CIRCULATION, V95, P1455
  • [9] Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein Al-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid
    Lindstedt, L
    Lee, M
    Castro, GR
    Fruchart, JC
    Kovanen, PT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) : 2174 - 2182
  • [10] MIURA S, 1994, J HYPERTENS, V12, P1177